These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 19670296)
81. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats. Chenel M; Barbot A; Dupuis A; Mimoz O; Paquereau J; Bouquet S; Couet W Antimicrob Agents Chemother; 2003 Jun; 47(6):1952-7. PubMed ID: 12760873 [TBL] [Abstract][Full Text] [Related]
82. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats. Dupuis A; Couet W; Paquereau J; Debarre S; Portron A; Jamois C; Bouquet S Antimicrob Agents Chemother; 2001 Jun; 45(6):1682-7. PubMed ID: 11353611 [TBL] [Abstract][Full Text] [Related]
83. Gemifloxacin for community-acquired pneumonia. Lode HM; Schmidt-Ionas M; Stahlmann R Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602 [TBL] [Abstract][Full Text] [Related]
84. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis. Jivcu C; Gotfried M Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863 [TBL] [Abstract][Full Text] [Related]
85. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections. Blondeau JM; Tillotson G Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120 [TBL] [Abstract][Full Text] [Related]
86. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections. Yoo BK; Triller DM; Yong CS; Lodise TP Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209 [TBL] [Abstract][Full Text] [Related]
87. Fluoroquinolones in the management of community-acquired pneumonia in primary care. Wispelwey B; Schafer KR Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291 [TBL] [Abstract][Full Text] [Related]